Researchers from the Mayo Clinic have reported findings from the preclinical evaluation of a novel cardiac targeting peptide (CTP)-based radiotracer – [68Ga]NOTA-CTP – being developed as a myocardial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback